fresh setback india pharmaceut export industri seri incid involv us washington food drug administr fda ha slap import ban sun pharmaceut industri plant karkhadi gujarat move sent mumbaibas drug maker share 5 rs bse thursday
ranbaxi laboratori wockhardt sun pharma ha becom fourth indian pharma compani face import ban us regul last decad backdrop intellectu properti row two nation use patent cheap drug
ranbaxi control japan daiichi sankyo india largest drug maker sale sun pharma leader term market capit
wednesday sun pharma facil wa put fda red list mean product detain us without physic examin usual reason cite detent failur adher good manufactur practic fda websit notif announc import crackdown give reason ban
thi import alert wa issu usfda followup last inspect facil dure noncompli current good manufactur practic regul identifi sun pharma said
compani said ha taken correct step address observ made regul ad financi impact ban plant make antibiot cephalosporin would neglig
contribut thi facil sun consolid revenu neglig said plant account less 1 consolid revenu
compani ha well diversifi manufactur infrastructur cater us market contribut 54 sale financi year 2013 said said sarabjit kour nangra pharma analyst angel broke
first publish mar 13 2014 ist
